NRIX CIK: 1549595

Nurix Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.31
FY22:
0.32
FY23:
0.30
FY24:
0.62
FY25:
0.61
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.17
FY22:
0.10
FY23:
0.06
FY24:
0.05
FY25:
0.08
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.48
FY22:
0.42
FY23:
0.36
FY24:
0.67
FY25:
0.69

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.07
FY22:
0.07
FY23:
0.09
FY24:
0.10
FY25:
0.09
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.07
FY22:
0.04
FY23:
0.07
FY24:
0.05
FY25:
0.06
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.34
FY22:
0.30
FY23:
0.20
FY24:
0.53
FY25:
0.54
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.48
FY22:
0.42
FY23:
0.36
FY24:
0.67
FY25:
0.69

All amounts in billions USD Data source:SEC EDGAR